Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
The federal government’s status is far from the only factor moving the markets on Friday. Two critical reports released today on producer inflation and the status of the U.S. cattle herd are also top of mind.
The changing political climate in America is leading to a drop in migrant crossings near the U.S.-Mexico border, where ranchers like Dr. Mike Vickers say they witnessed horrors from death to child trafficking.
Record milk output looks strong today, but shrinking replacement numbers mean future supply adjustments could be faster and more volatile.
A rapidly intensifying winter storm is expected to develop into a bomb cyclone this weekend, affecting the Southeast, southern Virginia, and potentially parts of the mid‑Atlantic and New England.
Brent Graves of StockShowAuctions.com takes us to Grayson County to see the damage from a historic winter ice storm and what it will take to rebuild.
Strong blending demand continues to support ethanol use even as production and exports fluctuate.
